Skip Navigation

Christopher Lathan, MD, MS, MPH


Medical Oncology

Make an Appointment
Watch Video

Physician

  • Medical Director, Dana-Farber Cancer Institute at St. Elizabeth's Medical Center
  • Faculty Director for Cancer Care Equity
  • Senior Network Physician
  • Assistant Professor of Medicine, Harvard Medical School

Clinical Interests

  • Lung cancer
  • Midline NUT carcinoma
  • Racial disparities in lung cancer treatment

Diseases Treated

Contact Information

  • Appointments617-562-7208 (New - St. Elizabeths)
    617-789-2903 (Follow-up - St. Elizabeths)
    617-632-6875 (new - Boston)
    617-632-6190 (follow-up - Boston)
  • Office Phone Number617-632-6041 (Boston main campus)
    617-789-2903 (St. Elizabeths)
  • Fax617-632-5786 (Boston main campus)
    617-789-2064 (St. Elizabeths)

Board Certification:

  • Internal Medicine
  • Medical Oncology, 2007

Fellowship:

  • Dana-Farber/Partners CancerCare, Medical Oncology

Residency:

  • Boston Medical Center, Chief Medical Resident
  • Boston Medical Center, Internal Medicine

Medical School:

  • Tufts University School of Medicine

Research

Community-based research, Health services research

My primary research interests and clinical work focuses on care provided to lung cancer patients, particularly patients who are members of ethnic and racial minority groups. I am interested in all areas of care delivery and feel that community engagement and assessment is of utmost importance.  Cancer patients are vulnerable and knowledge about the distribution of symptoms both physical and psychological is invaluable in the assessment of disparities.

My current research interests focus on racial disparities in lung cancer, and on improving access to care for underserved cancer patients. Currently I am involved with the Lung Cancer Disparities Center run by Dr. David Williams at the Harvard School of Public Health as an co- investigator on multiple projects including (1) sequencing somatic mutations in African-Americans with lung cancer. (2) Examining socioeconomic changes in the NCI CanCORS data set. (3) Examining the relative effects of socioeconomic status on survival in lung cancer. In addition am currently running an outreach oncology clinic as in a Federally Qualified health center in Roxbury, MA.  This program is an innovative project with the aim of reducing disparities in cancer mortality locally.

Apaydin KZ, Fontenot HB, Shtasel D, Dale SK, Borba CPC, Lathan CS, Panther L, Mayer KH, Keuroghlian AS. Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center. Vaccine. 2018 06 18; 36(26):3868-3875.
View in: PubMed

Vastola ME, Yang DD, Muralidhar V, Mahal BA, Lathan CS, McGregor BA, Nguyen PL. Laboratory Eligibility Criteria as Potential Barriers to Participation by Black Men in Prostate Cancer Clinical Trials. JAMA Oncol. 2018 Mar 01; 4(3):413-414.
View in: PubMed

Rana HQ, Cochrane SR, Hiller E, Akindele RN, Nibecker CM, Svoboda LA, Cronin AM, Garber JE, Lathan CS. A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settings. J Community Genet. 2018 Jul; 9(3):233-241.
View in: PubMed

Gilligan T, Coyle N, Frankel RM, Berry DL, Bohlke K, Epstein RM, Finlay E, Jackson VA, Lathan CS, Loprinzi CL, Nguyen LH, Seigel C, Baile WF. Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline. J Clin Oncol. 2017 Nov 01; 35(31):3618-3632.
View in: PubMed

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED. Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. CA Cancer J Clin. 2017 09; 67(5):353-361.
View in: PubMed

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED. Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. J Clin Oncol. 2017 Sep 10; 35(26):3075-3082.
View in: PubMed

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED. Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. Cancer Res. 2017 09 01; 77(17):4548-4555.
View in: PubMed

Cooley ME, Nayak MM, Abrahm JL, Braun IM, Rabin MS, Brzozowski J, Lathan C, Berry DL. Patient and caregiver perspectives on decision support for symptom and quality of life management during cancer treatment: Implications for eHealth. Psychooncology. 2017 Aug; 26(8):1105-1112.
View in: PubMed

Campbell JD, Lathan C, Sholl L, Ducar M, Vega M, Sunkavalli A, Lin L, Hanna M, Schubert L, Thorner A, Faris N, Williams DR, Osarogiagbon RU, van Hummelen P, Meyerson M, MacConaill L. Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations. JAMA Oncol. 2017 Jun 01; 3(6):801-809.
View in: PubMed

Soneji S, Tanner NT, Silvestri GA, Lathan CS, Black W. Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival. Chest. 2017 09; 152(3):587-597.
View in: PubMed

Osarogiagbon RU, Rodriguez HP, Hicks D, Signore RS, Roark K, Kedia SK, Ward KD, Lathan C, Santarella S, Gould MK, Krasna MJ. Deploying Team Science Principles to Optimize Interdisciplinary Lung Cancer Care Delivery: Avoiding the Long and Winding Road to Optimal Care. J Oncol Pract. 2016 Nov; 12(11):983-991.
View in: PubMed

Chau NG, Hurwitz S, Mitchell CM, Aserlind A, Grunfeld N, Kaplan L, Hsi P, Bauer DE, Lathan CS, Rodriguez-Galindo C, Tishler RB, Haddad RI, Sallan SE, Bradner JE, French CA. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck. Cancer. 2016 Dec 01; 122(23):3632-3640.
View in: PubMed

Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D. Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer. J Clin Oncol. 2016 05 20; 34(15):1732-40.
View in: PubMed

Kumar P, Gareen IF, Lathan C, Sicks JD, Perez GK, Hyland KA, Park ER. Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial. Oncologist. 2016 Jan; 21(1):40-9.
View in: PubMed

Lathan CS. Lung cancer care: the impact of facilities and area measures. Transl Lung Cancer Res. 2015 Aug; 4(4):385-91.
View in: PubMed

Sholl LM, Nishino M, Pokharel S, Mino-Kenudson M, French CA, Janne PA, Lathan C. Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations. J Thorac Oncol. 2015 Jun; 10(6):951-9.
View in: PubMed

Lathan CS, Waldman LT, Browning E, Gagne J, Emmons K. Perspectives of African Americans on lung cancer: a qualitative analysis. Oncologist. 2015 Apr; 20(4):393-9.
View in: PubMed

Warren JL, Butler EN, Stevens J, Lathan CS, Noone AM, Ward KC, Harlan LC. Receipt of chemotherapy among medicare patients with cancer by type of supplemental insurance. J Clin Oncol. 2015 Feb 01; 33(4):312-8.
View in: PubMed

Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study. J Oncol Pract. 2015 Mar; 11(2):145-50.
View in: PubMed

Polite BN, Griggs JJ, Moy B, Lathan C, duPont NC, Villani G, Wong SL, Halpern MT. American Society of Clinical Oncology policy statement on medicaid reform. J Clin Oncol. 2014 Dec 20; 32(36):4162-7.
View in: PubMed

Ziehr DR, Mahal BA, Aizer AA, Hyatt AS, Beard CJ, D Amico AV, Choueiri TK, Elfiky A, Lathan CS, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL. Income inequality and treatment of African American men with high-risk prostate cancer. Urol Oncol. 2015 Jan; 33(1):18.e7-18.e13.
View in: PubMed

John DA, Kawachi I, Lathan CS, Ayanian JZ. Disparities in perceived unmet need for supportive services among patients with lung cancer in the Cancer Care Outcomes Research and Surveillance Consortium. Cancer. 2014 Oct 15; 120(20):3178-91.
View in: PubMed

Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Lago-Hernandez C, Choueiri TK, Elfiky AA, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Lathan CS, Trinh QD, Nguyen PL. Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer. J Geriatr Oncol. 2014 Oct 01; 5(4):352-8.
View in: PubMed

Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Sammon JD, Schmid M, Choueiri TK, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Lathan C, Kim SP, Trinh QD, Nguyen PL. Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer. Urol Oncol. 2014 Nov; 32(8):1285-91.
View in: PubMed

Yasuda H, Park E, Yun CH, Sng NJ, Lucena-Araujo AR, Yeo WL, Huberman MS, Cohen DW, Nakayama S, Ishioka K, Yamaguchi N, Hanna M, Oxnard GR, Lathan CS, Moran T, Sequist LV, Chaft JE, Riely GJ, Arcila ME, Soo RA, Meyerson M, Eck MJ, Kobayashi SS, Costa DB. Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer. Sci Transl Med. 2013 Dec 18; 5(216):216ra177.
View in: PubMed

Waldman LT, Svoboda L, Young BF, Abel GA, Berlin S, Elfiky AA, Freedman RA, Drews M, Holland L, Lathan CS. A novel community-based delivery model to combat cancer disparities. Healthc (Amst). 2013 Dec; 1(3-4):123-9.
View in: PubMed

Traeger L, Cannon S, Keating NL, Pirl WF, Lathan C, Martin MY, He Y, Park ER. Race by sex differences in depression symptoms and psychosocial service use among non-Hispanic black and white patients with lung cancer. J Clin Oncol. 2014 Jan 10; 32(2):107-13.
View in: PubMed

Waldman LT, Bean W, Levine AL, Cohen-Bearak A, Phelps FA, Svoboda L, Freedman R, Elfiky A, Berlin S, Abel GA, Deutsch C, Lathan CS. Using FastTrack to Implement an Academic Medical Center and Community Health Center Collaborative for Cancer Care Delivery. Healthc (Amst). 2013 Dec; 1(3-4):130-135.
View in: PubMed

Lynch JA, Khoury MJ, Borzecki A, Cromwell J, Hayman LL, Ponte PR, Miller GA, Lathan CS. Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research. Genet Med. 2013 Aug; 15(8):630-8.
View in: PubMed

Jimenez R, Zhang B, Joffe S, Nilsson M, Rivera L, Mutchler J, Lathan C, Paulk ME, Prigerson HG. Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment? J Palliat Med. 2013 Mar; 16(3):256-62.
View in: PubMed

Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Lüer SC, Muhammed S, Evans AG, Sholl LM, Rosai J, Giraldi E, Oakley RP, Rodriguez-Galindo C, London WB, Sallan SE, Bradner JE, French CA. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res. 2012 Oct 15; 18(20):5773-9.
View in: PubMed

Gray SW, Hicks-Courant K, Lathan CS, Garraway L, Park ER, Weeks JC. Attitudes of patients with cancer about personalized medicine and somatic genetic testing. J Oncol Pract. 2012 Nov; 8(6):329-35, 2 p following 335.
View in: PubMed

Evans AG, French CA, Cameron MJ, Fletcher CD, Jackman DM, Lathan CS, Sholl LM. Pathologic characteristics of NUT midline carcinoma arising in the mediastinum. Am J Surg Pathol. 2012 Aug; 36(8):1222-7.
View in: PubMed

Williams DR, Kontos EZ, Viswanath K, Haas JS, Lathan CS, MacConaill LE, Chen J, Ayanian JZ. Integrating multiple social statuses in health disparities research: the case of lung cancer. Health Serv Res. 2012 Jun; 47(3 Pt 2):1255-77.
View in: PubMed

Sasaki T, Koivunen J, Ogino A, Yanagita M, Nikiforow S, Zheng W, Lathan C, Marcoux JP, Du J, Okuda K, Capelletti M, Shimamura T, Ercan D, Stumpfova M, Xiao Y, Weremowicz S, Butaney M, Heon S, Wilner K, Christensen JG, Eck MJ, Wong KK, Lindeman N, Gray NS, Rodig SJ, Jänne PA. A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors. Cancer Res. 2011 Sep 15; 71(18):6051-60.
View in: PubMed

Lathan CS, Cronin A, Weeks JC. Factors associated with histologic versus cytologic diagnosis of lung cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):6048.
View in: PubMed

Jimenez R, Zhang B, Nilsson ME, Joffe S, Lathan C, Prigerson HG. Clinical trial participation among patients with advanced cancer: What characteristics most influence enrollment? J Clin Oncol. 2011 May 20; 29(15_suppl):9073.
View in: PubMed

Balboni T, Balboni M, Paulk ME, Phelps A, Wright A, Peteet J, Block S, Lathan C, Vanderweele T, Prigerson H. Support of cancer patients' spiritual needs and associations with medical care costs at the end of life. Cancer. 2011 Dec 01; 117(23):5383-91.
View in: PubMed

Balboni T, Balboni M, Paulk ME, Phelps A, Wright A, Peteet J, Block S, Lathan C, VanderWeele T, Prigerson H. Support of Cancer Patients' Spiritual Needs and Associations with Medical Care Costs at the End of Life (419-C). J Pain Symptom Manage. 2011 Jan; 41(1):243-4.
View in: PubMed

Lathan CS, Okechukwu C, Drake BF, Bennett GG. Racial differences in the perception of lung cancer: the 2005 Health Information National Trends Survey. Cancer. 2010 Apr 15; 116(8):1981-6.
View in: PubMed

Lathan CS. Commentary: One Small Step. J Oncol Pract. 2009 Nov; 5(6):317-318.
View in: PubMed

Schapira L, Gordon-Rowe L, Martignetti R, Washington D, Bartholomay M, Greenberg D, Lathan C, LaFrancesca J, Lynch T, Chabner B. Racism in the chemotherapy infusion unit: a nurse's story. Oncologist. 2008 Nov; 13(11):1177-80.
View in: PubMed

Lathan CS, Neville BA, Earle CC. Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer. J Clin Oncol. 2008 Sep 10; 26(26):4347-52.
View in: PubMed

Drake BF, Lathan CS, Okechukwu CA, Bennett GG. Racial differences in prostate cancer screening by family history. Ann Epidemiol. 2008 Jul; 18(7):579-83.
View in: PubMed

Balboni TA, Vanderwerker LC, Block SD, Paulk ME, Lathan CS, Peteet JR, Prigerson HG. Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life. J Clin Oncol. 2007 Feb 10; 25(5):555-60.
View in: PubMed

Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol. 2006 Jan 20; 24(3):413-8.
View in: PubMed

Blackstock AW, Herndon JE, Paskett ED, Miller AA, Lathan C, Niell HB, Socinski MA, Vokes EE, Green MR. Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: report from the Cancer and Leukemia Group B. J Clin Oncol. 2006 Jan 20; 24(3):407-12.
View in: PubMed

Lathan CS, Neville BA, Earle CC. The effect of hospital racial composition on obtaining surgery for non-metastatic small cell lung cancer (NSCLC). J Clin Oncol. 2005 Jun; 23(16_suppl):6019.
View in: PubMed

Lathan CS, Neville BA, Earle CC. The effect of race on recommendation and acceptance of surgical resection for non-metastatic non-small cell lung cancer (NSCLC). J Clin Oncol. 2004 Jul 15; 22(14_suppl):6018.
View in: PubMed

Research Departments:

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston MA, 02215
Get Directions

Dana-Farber Cancer Institute at St. Elizabeth's Medical Center
736 Cambridge Street
Brighton MA, 02135
Get Directions

Top